Clinical Evaluation Of Kshaumadi Karnadhoopana And Rasnaadi Guggulu in Karnasrava (Chronic Suppurative Otitis Media)

Uttarakhand Ayurved University Dehradun1 个研究点分布在 1 个国家目标入组 40 人开始时间: 2024年10月8日最近更新: 2024年9月26日

试验速览

阶段: 2 期
状态: 尚未招募
发起方
入组人数: 40
试验地点: 1
主要终点: Relief in sign and symptoms-

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Among 28 ear diseases mentioned by Acharya Sushruta Karnasrava is one of them. Available treatment protocols for CSOM in modern system of medicine relies upon antibiotics and pain killers.

CSOM is a frustrating entity for both patients and otolaryngologists as it requires long term treatment and medications used for its treatment has limitations like acidity, loss of hearing and unusual taste in mouth.

So the present study will be planned to study the effect of Ayurvedic formulation on Karnasrava.

Case will be selected from OPD/IPD of Rishikul Campus Hospital, U.A.U. Haridwar (UK) INDIA.

A written informed consent will be obtained after counselling of patients participating in the study.

Patients will be treated with Dhoopana therapy, local application and oral drug.

研究设计

研究类型: Interventional
分配方式: Randomized
盲法: None

入排标准

年龄范围: 16.00 Year(s) 至 60.00 Year(s)（—）
性别: All

入选标准

•1.Patients willing to register 2.Patients within the age group ofÂ 16-60Â years 3.Patients having specific signs and symptoms of CSOM and karnasrava 4.Tubotympanic (SAFE) type of CSOM 5.Active cases of Tubotympanic CSOM with chronicity less than 2yrs.

排除标准

•1 Patients not willing to participate in the study.
•2 Pregnant women and lactating mothers.
•3 Patients with the complications of CSOM.
•4 Systemic diseases like DM, Meningitis, Tuberculosis, etc.
•5 Atticoantral (Unsafe) type of CSOM.
•6 Non- vaccinated Covid-19 patients.